Facebook
Twitter
LinkedIn
Forward- KATHLEEN MAHER
- Nada Rashid
Series Overview
Project ECHO® (Extension for Community Healthcare Outcomes) is a statewide educational, teleECHO initiative that connects clinical experts with primary care providers and medication assisted treatment prescribers across Wisconsin in an effort to reduce substance-related complications. Via a regularly scheduled videoconference, a multidisciplinary panel of specialists provide education and lead a collaborative discussion on submitted patient cases. This effort is sponsored by UW Department of Family Medicine and Community Health and the Wisconsin Department of Health Services, Division of Care and Treatment Services. Funding for this project was made possible by grant 435200-G-18-11448-285932-880 from the Substance Abuse and Mental Health Services Administration. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official polices of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Sign-up to receive email notifications regarding upcoming sessions: https://www.fammed.wisc.edu/echo/alerts/
For more information visit our webpage: https://www.fammed.wisc.edu/echo/
Target Audience
Target Audience: Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, Pharmacy Technicians, Psychologists, Social Workers, Patient/Caregivers, Students
Planning Committee
| Randy Brown, MD PhD, Chair | Nada Rashid, Coordinator |
| Sheila Weix, MSN, RN, CARN | Ritu Bhatnagar, DO |
| Lindsey Peterson, MS, CRC | Paul Hutson, PharmD |
| Susan Mindock, LPC, CSAC | Kathleen Maher, Coordinator |
| Joeseph Galey, CPS | Kellene Eagen, MD |
Accreditation
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1 hour of knowledge-based CE credit. Credit can be earned by successfully completing this live activity. Pharmacists and Pharmacy Technicians should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion.
Pharmacists and Pharmacy Technicians must enter their NABP number in their profile in order to receive credit.
2020 Universal Activity Number (UAN) JA0000358-9999-20-141-L01-P
2021 Universal Activity Number (UAN) JA0000358-9999-21-065-L01-P
2022 Universal Activity Number (UAN) JA0000358-9999-22-002-L01-P
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Disclosures for Planning Committee
Disclosures for Planning Committee - March 1, 2022 to June 30, 2022
As a result of participation in this educational series participant will increase their ability to:
- Effectively participate in collaborative management of substance use disorders in outpatient and inpatient settings.
- Examine the public health impact of substance use, misuse, and substance use disorders.
- Identify the role of medications, such as methadone, naltrexone, and buprenorphine, in substance use disorder management.
- Discuss the roles of different members of the healthcare team in the management of substance use disorders and related conditions.
- Implement appropriate opioid prescribing and monitoring practices.
- Consistently provide overdose prevention education to appropriate patients.